Global Oxycodone Sales Market Report 2021

Publisher Name :
Date: 30-Apr-2021
No. of pages: 127
Inquire Before Buying

The global Oxycodone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oxycodone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Long Acting Oxycodone

- Short Acting Oxycodone

Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- Others

The Oxycodone market is analysed and market size information is provided by regions (countries). Segment by Application, the Oxycodone market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Johnson & Johnson

- Sanofi

- Pfizer

- Purdue Pharma

- Endo International

- Teva Pharmaceuticals

- Hikma Pharmaceuticals (West-Ward Pharmaceuticals)

- Mallinckrodt

- Mylan

- Sun Pharmaceutical (Chattem Chemicals)

- Impax Laboratories

- Indivior

Global Oxycodone Sales Market Report 2021

Table of Contents
1 Oxycodone Market Overview
1.1 Oxycodone Product Scope
1.2 Oxycodone Segment by Type
1.2.1 Global Oxycodone Sales by Type (2016 & 2021 & 2027)
1.2.2 Long Acting Oxycodone
1.2.3 Short Acting Oxycodone
1.3 Oxycodone Segment by Application
1.3.1 Global Oxycodone Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Oxycodone Market Estimates and Forecasts (2016-2027)
1.4.1 Global Oxycodone Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Oxycodone Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Oxycodone Price Trends (2016-2027)
2 Oxycodone Estimates and Forecasts by Region
2.1 Global Oxycodone Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Oxycodone Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Oxycodone Sales Market Share by Region (2016-2021)
2.2.2 Global Oxycodone Revenue Market Share by Region (2016-2021)
2.3 Global Oxycodone Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Oxycodone Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Oxycodone Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Oxycodone Estimates and Projections (2016-2027)
2.4.2 Europe Oxycodone Estimates and Projections (2016-2027)
2.4.3 China Oxycodone Estimates and Projections (2016-2027)
2.4.4 Japan Oxycodone Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Oxycodone Estimates and Projections (2016-2027)
2.4.6 India Oxycodone Estimates and Projections (2016-2027)
3 Global Oxycodone Competition Landscape by Players
3.1 Global Top Oxycodone Players by Sales (2016-2021)
3.2 Global Top Oxycodone Players by Revenue (2016-2021)
3.3 Global Oxycodone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oxycodone as of 2020)
3.4 Global Oxycodone Average Price by Company (2016-2021)
3.5 Manufacturers Oxycodone Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Oxycodone Market Size by Type
4.1 Global Oxycodone Historic Market Review by Type (2016-2021)
4.1.1 Global Oxycodone Sales Market Share by Type (2016-2021)
4.1.2 Global Oxycodone Revenue Market Share by Type (2016-2021)
4.1.3 Global Oxycodone Price by Type (2016-2021)
4.2 Global Oxycodone Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Oxycodone Sales Forecast by Type (2022-2027)
4.2.2 Global Oxycodone Revenue Forecast by Type (2022-2027)
4.2.3 Global Oxycodone Price Forecast by Type (2022-2027)
5 Global Oxycodone Market Size by Application
5.1 Global Oxycodone Historic Market Review by Application (2016-2021)
5.1.1 Global Oxycodone Sales Market Share by Application (2016-2021)
5.1.2 Global Oxycodone Revenue Market Share by Application (2016-2021)
5.1.3 Global Oxycodone Price by Application (2016-2021)
5.2 Global Oxycodone Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Oxycodone Sales Forecast by Application (2022-2027)
5.2.2 Global Oxycodone Revenue Forecast by Application (2022-2027)
5.2.3 Global Oxycodone Price Forecast by Application (2022-2027)
6 North America Oxycodone Market Facts & Figures
6.1 North America Oxycodone Sales by Company
6.1.1 North America Oxycodone Sales by Company (2016-2021)
6.1.2 North America Oxycodone Revenue by Company (2016-2021)
6.2 North America Oxycodone Sales Breakdown by Type
6.2.1 North America Oxycodone Sales Breakdown by Type (2016-2021)
6.2.2 North America Oxycodone Sales Breakdown by Type (2022-2027)
6.3 North America Oxycodone Sales Breakdown by Application
6.3.1 North America Oxycodone Sales Breakdown by Application (2016-2021)
6.3.2 North America Oxycodone Sales Breakdown by Application (2022-2027)
7 Europe Oxycodone Market Facts & Figures
7.1 Europe Oxycodone Sales by Company
7.1.1 Europe Oxycodone Sales by Company (2016-2021)
7.1.2 Europe Oxycodone Revenue by Company (2016-2021)
7.2 Europe Oxycodone Sales Breakdown by Type
7.2.1 Europe Oxycodone Sales Breakdown by Type (2016-2021)
7.2.2 Europe Oxycodone Sales Breakdown by Type (2022-2027)
7.3 Europe Oxycodone Sales Breakdown by Application
7.3.1 Europe 127 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 127 Sales Breakdown by Application (2022-2027)
8 China Oxycodone Market Facts & Figures
8.1 China Oxycodone Sales by Company
8.1.1 China Oxycodone Sales by Company (2016-2021)
8.1.2 China Oxycodone Revenue by Company (2016-2021)
8.2 China Oxycodone Sales Breakdown by Type
8.2.1 China Oxycodone Sales Breakdown by Type (2016-2021)
8.2.2 China Oxycodone Sales Breakdown by Type (2022-2027)
8.3 China Oxycodone Sales Breakdown by Application
8.3.1 China 155 Sales Breakdown by Application (2016-2021)
8.3.2 China 155 Sales Breakdown by Application (2022-2027)
9 Japan Oxycodone Market Facts & Figures
9.1 Japan Oxycodone Sales by Company
9.1.1 Japan Oxycodone Sales by Company (2016-2021)
9.1.2 Japan Oxycodone Revenue by Company (2016-2021)
9.2 Japan Oxycodone Sales Breakdown by Type
9.2.1 Japan Oxycodone Sales Breakdown by Type (2016-2021)
9.2.2 Japan Oxycodone Sales Breakdown by Type (2022-2027)
9.3 Japan Oxycodone Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Oxycodone Market Facts & Figures
10.1 Southeast Asia Oxycodone Sales by Company
10.1.1 Southeast Asia Oxycodone Sales by Company (2016-2021)
10.1.2 Southeast Asia Oxycodone Revenue by Company (2016-2021)
10.2 Southeast Asia Oxycodone Sales Breakdown by Type
10.2.1 Southeast Asia Oxycodone Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Oxycodone Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Oxycodone Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India Oxycodone Market Facts & Figures
11.1 India Oxycodone Sales by Company
11.1.1 India Oxycodone Sales by Company (2016-2021)
11.1.2 India Oxycodone Revenue by Company (2016-2021)
11.2 India Oxycodone Sales Breakdown by Type
11.2.1 India Oxycodone Sales Breakdown by Type (2016-2021)
11.2.2 India Oxycodone Sales Breakdown by Type (2022-2027)
11.3 India Oxycodone Sales Breakdown by Application
11.3.1 India Oxycodone Sales Breakdown by Application (2016-2021)
11.3.2 India Oxycodone Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Oxycodone Business
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Business Overview
12.1.3 Johnson & Johnson Oxycodone Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Johnson & Johnson Oxycodone Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Business Overview
12.2.3 Sanofi Oxycodone Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi Oxycodone Products Offered
12.2.5 Sanofi Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Oxycodone Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Oxycodone Products Offered
12.3.5 Pfizer Recent Development
12.4 Purdue Pharma
12.4.1 Purdue Pharma Corporation Information
12.4.2 Purdue Pharma Business Overview
12.4.3 Purdue Pharma Oxycodone Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Purdue Pharma Oxycodone Products Offered
12.4.5 Purdue Pharma Recent Development
12.5 Endo International
12.5.1 Endo International Corporation Information
12.5.2 Endo International Business Overview
12.5.3 Endo International Oxycodone Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Endo International Oxycodone Products Offered
12.5.5 Endo International Recent Development
12.6 Teva Pharmaceuticals
12.6.1 Teva Pharmaceuticals Corporation Information
12.6.2 Teva Pharmaceuticals Business Overview
12.6.3 Teva Pharmaceuticals Oxycodone Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Pharmaceuticals Oxycodone Products Offered
12.6.5 Teva Pharmaceuticals Recent Development
12.7 Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
12.7.1 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Corporation Information
12.7.2 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Business Overview
12.7.3 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Products Offered
12.7.5 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Development
12.8 Mallinckrodt
12.8.1 Mallinckrodt Corporation Information
12.8.2 Mallinckrodt Business Overview
12.8.3 Mallinckrodt Oxycodone Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Mallinckrodt Oxycodone Products Offered
12.8.5 Mallinckrodt Recent Development
12.9 Mylan
12.9.1 Mylan Corporation Information
12.9.2 Mylan Business Overview
12.9.3 Mylan Oxycodone Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Mylan Oxycodone Products Offered
12.9.5 Mylan Recent Development
12.10 Sun Pharmaceutical (Chattem Chemicals)
12.10.1 Sun Pharmaceutical (Chattem Chemicals) Corporation Information
12.10.2 Sun Pharmaceutical (Chattem Chemicals) Business Overview
12.10.3 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Products Offered
12.10.5 Sun Pharmaceutical (Chattem Chemicals) Recent Development
12.11 Impax Laboratories
12.11.1 Impax Laboratories Corporation Information
12.11.2 Impax Laboratories Business Overview
12.11.3 Impax Laboratories Oxycodone Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Impax Laboratories Oxycodone Products Offered
12.11.5 Impax Laboratories Recent Development
12.12 Indivior
12.12.1 Indivior Corporation Information
12.12.2 Indivior Business Overview
12.12.3 Indivior Oxycodone Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Indivior Oxycodone Products Offered
12.12.5 Indivior Recent Development
13 Oxycodone Manufacturing Cost Analysis
13.1 Oxycodone Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oxycodone
13.4 Oxycodone Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oxycodone Distributors List
14.3 Oxycodone Customers
15 Market Dynamics
15.1 Oxycodone Market Trends
15.2 Oxycodone Drivers
15.3 Oxycodone Market Challenges
15.4 Oxycodone Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Oxycodone Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Oxycodone Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Oxycodone Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Oxycodone Sales (K Pcs) by Region (2016-2021)
Table 5. Global Oxycodone Sales Market Share by Region (2016-2021)
Table 6. Global Oxycodone Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Oxycodone Revenue Share by Region (2016-2021)
Table 8. Global Oxycodone Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Oxycodone Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Oxycodone Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Oxycodone Revenue Share Forecast by Region (2022-2027)
Table 12. Global Oxycodone Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Oxycodone Sales Share by Company (2016-2021)
Table 14. Global Oxycodone Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Oxycodone Revenue Share by Company (2016-2021)
Table 16. Global Oxycodone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxycodone as of 2020)
Table 17. Global Oxycodone Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Oxycodone Manufacturing Sites and Area Served
Table 19. Manufacturers Oxycodone Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Oxycodone Sales (K Pcs) by Type (2016-2021)
Table 22. Global Oxycodone Sales Share by Type (2016-2021)
Table 23. Global Oxycodone Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Oxycodone Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Oxycodone Sales Share by Type (2022-2027)
Table 26. Global Oxycodone Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Oxycodone Revenue Share by Type (2022-2027)
Table 28. Global Oxycodone Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Oxycodone Sales (K Pcs) by Application (2016-2021)
Table 30. Global Oxycodone Sales Share by Application (2016-2021)
Table 31. Global Oxycodone Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Oxycodone Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Oxycodone Sales (K Pcs) by Application (2022-2027)
Table 34. Global Oxycodone Sales Share by Application (2022-2027)
Table 35. Global Oxycodone Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Oxycodone Revenue Share by Application (2022-2027)
Table 37. Global Oxycodone Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Oxycodone Sales (K Pcs) by Company (2016-2021)
Table 39. North America Oxycodone Sales Market Share by Company (2016-2021)
Table 40. North America Oxycodone Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Oxycodone Revenue Market Share by Company (2016-2021)
Table 42. North America Oxycodone Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Oxycodone Sales Market Share by Type (2016-2021)
Table 44. North America Oxycodone Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Oxycodone Sales Market Share by Type (2022-2027)
Table 46. North America Oxycodone Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Oxycodone Sales Market Share by Application (2016-2021)
Table 48. North America Oxycodone Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Oxycodone Sales Market Share by Application (2022-2027)
Table 50. Europe Oxycodone Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Oxycodone Sales Market Share by Company (2016-2021)
Table 52. Europe Oxycodone Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Oxycodone Revenue Market Share by Company (2016-2021)
Table 54. Europe Oxycodone Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Oxycodone Sales Market Share by Type (2016-2021)
Table 56. Europe Oxycodone Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Oxycodone Sales Market Share by Type (2022-2027)
Table 58. Europe Oxycodone Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Oxycodone Sales Market Share by Application (2016-2021)
Table 60. Europe Oxycodone Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Oxycodone Sales Market Share by Application (2022-2027)
Table 62. China Oxycodone Sales (K Pcs) by Company (2016-2021)
Table 63. China Oxycodone Sales Market Share by Company (2016-2021)
Table 64. China Oxycodone Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Oxycodone Revenue Market Share by Company (2016-2021)
Table 66. China Oxycodone Sales by Type (2016-2021) & (K Pcs)
Table 67. China Oxycodone Sales Market Share by Type (2016-2021)
Table 68. China Oxycodone Sales by Type (2022-2027) & (K Pcs)
Table 69. China Oxycodone Sales Market Share by Type (2022-2027)
Table 70. China Oxycodone Sales by Application (2016-2021) & (K Pcs)
Table 71. China Oxycodone Sales Market Share by Application (2016-2021)
Table 72. China Oxycodone Sales by Application (2022-2027) & (K Pcs)
Table 73. China Oxycodone Sales Market Share by Application (2022-2027)
Table 74. Japan Oxycodone Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Oxycodone Sales Market Share by Company (2016-2021)
Table 76. Japan Oxycodone Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Oxycodone Revenue Market Share by Company (2016-2021)
Table 78. Japan Oxycodone Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Oxycodone Sales Market Share by Type (2016-2021)
Table 80. Japan Oxycodone Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Oxycodone Sales Market Share by Type (2022-2027)
Table 82. Japan Oxycodone Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Oxycodone Sales Market Share by Application (2016-2021)
Table 84. Japan Oxycodone Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Oxycodone Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Oxycodone Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Oxycodone Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Oxycodone Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Oxycodone Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Oxycodone Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Oxycodone Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Oxycodone Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Oxycodone Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Oxycodone Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Oxycodone Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Oxycodone Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Oxycodone Sales Market Share by Application (2022-2027)
Table 98. India Oxycodone Sales (K Pcs) by Company (2016-2021)
Table 99. India Oxycodone Sales Market Share by Company (2016-2021)
Table 100. India Oxycodone Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Oxycodone Revenue Market Share by Company (2016-2021)
Table 102. India Oxycodone Sales by Type (2016-2021) & (K Pcs)
Table 103. India Oxycodone Sales Market Share by Type (2016-2021)
Table 104. India Oxycodone Sales by Type (2022-2027) & (K Pcs)
Table 105. India Oxycodone Sales Market Share by Type (2022-2027)
Table 106. India Oxycodone Sales by Application (2016-2021) & (K Pcs)
Table 107. India Oxycodone Sales Market Share by Application (2016-2021)
Table 108. India Oxycodone Sales by Application (2022-2027) & (K Pcs)
Table 109. India Oxycodone Sales Market Share by Application (2022-2027)
Table 110. Johnson & Johnson Corporation Information
Table 111. Johnson & Johnson Description and Business Overview
Table 112. Johnson & Johnson Oxycodone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Johnson & Johnson Oxycodone Product
Table 114. Johnson & Johnson Recent Development
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Oxycodone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Sanofi Oxycodone Product
Table 119. Sanofi Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Oxycodone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Pfizer Oxycodone Product
Table 124. Pfizer Recent Development
Table 125. Purdue Pharma Corporation Information
Table 126. Purdue Pharma Description and Business Overview
Table 127. Purdue Pharma Oxycodone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Purdue Pharma Oxycodone Product
Table 129. Purdue Pharma Recent Development
Table 130. Endo International Corporation Information
Table 131. Endo International Description and Business Overview
Table 132. Endo International Oxycodone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Endo International Oxycodone Product
Table 134. Endo International Recent Development
Table 135. Teva Pharmaceuticals Corporation Information
Table 136. Teva Pharmaceuticals Description and Business Overview
Table 137. Teva Pharmaceuticals Oxycodone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Teva Pharmaceuticals Oxycodone Product
Table 139. Teva Pharmaceuticals Recent Development
Table 140. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Corporation Information
Table 141. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Description and Business Overview
Table 142. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product
Table 144. Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Development
Table 145. Mallinckrodt Corporation Information
Table 146. Mallinckrodt Oxycodone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Mallinckrodt Description and Business Overview
Table 148. Mallinckrodt Oxycodone Product
Table 149. Mallinckrodt Recent Development
Table 150. Mylan Corporation Information
Table 151. Mylan Oxycodone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Mylan Description and Business Overview
Table 153. Mylan Oxycodone Product
Table 154. Mylan Recent Development
Table 155. Sun Pharmaceutical (Chattem Chemicals) Corporation Information
Table 156. Sun Pharmaceutical (Chattem Chemicals) Description and Business Overview
Table 157. Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product
Table 159. Sun Pharmaceutical (Chattem Chemicals) Recent Development
Table 160. Impax Laboratories Corporation Information
Table 161. Impax Laboratories Description and Business Overview
Table 162. Impax Laboratories Oxycodone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Impax Laboratories Oxycodone Product
Table 164. Impax Laboratories Recent Development
Table 165. Indivior Corporation Information
Table 166. Indivior Description and Business Overview
Table 167. Indivior Oxycodone Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Indivior Oxycodone Product
Table 169. Indivior Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Oxycodone Distributors List
Table 173. Oxycodone Customers List
Table 174. Oxycodone Market Trends
Table 175. Oxycodone Market Drivers
Table 176. Oxycodone Market Challenges
Table 177. Oxycodone Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxycodone Product Picture
Figure 2. Global Oxycodone Sales Market Share by Type in 2021 & 2027
Figure 3. Long Acting Oxycodone Product Picture
Figure 4. Short Acting Oxycodone Product Picture
Figure 5. Global Oxycodone Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Others Examples
Figure 9. Global Oxycodone Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Oxycodone Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Oxycodone Sales (K Pcs) Growth Rate (2016-2027)
Figure 12. Global Oxycodone Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 13. Global Oxycodone Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Oxycodone Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Oxycodone Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Oxycodone Sales (K Pcs) Growth Rate (2016-2027)
Figure 17. Europe Oxycodone Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Oxycodone Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Oxycodone Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Oxycodone Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Oxycodone Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Oxycodone Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Oxycodone Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Oxycodone Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Oxycodone Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Oxycodone Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Oxycodone Players Market Share by Revenue in Oxycodone: 2016 & 2020
Figure 28. Oxycodone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Oxycodone Revenue Share by Type (2016-2021)
Figure 30. Global Oxycodone Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Oxycodone Revenue Share by Application (2016-2021)
Figure 32. Global Oxycodone Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Oxycodone Sales Market Share by Type in 2020
Figure 34. North America Oxycodone Sales Market Share by Application in 2020
Figure 35. Europe Oxycodone Sales Market Share by Type in 2020
Figure 36. Europe Oxycodone Sales Market Share by Application in 2020
Figure 37. China Oxycodone Sales Market Share by Type in 2020
Figure 38. China Oxycodone Sales Market Share by Application in 2020
Figure 39. Japan Oxycodone Sales Market Share by Type in 2020
Figure 40. Japan Oxycodone Sales Market Share by Application in 2020
Figure 41. Southeast Asia Oxycodone Sales Market Share by Type in 2020
Figure 42. Southeast Asia Oxycodone Sales Market Share by Application in 2020
Figure 43. India Oxycodone Sales Market Share by Type in 2020
Figure 44. India Oxycodone Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Oxycodone
Figure 47. Manufacturing Process Analysis of Oxycodone
Figure 48. Oxycodone Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs